Citation Impact
Citing Papers
Chapter 1 Ginsenosides
2008 Standout
Microbiota in health and diseases
2022 Standout
Bile acid receptors as targets for the treatment of dyslipidemia and cardiovascular disease
2012
Fibrates and future PPARα agonists in the treatment of cardiovascular disease
2008
Bile acid–microbiota crosstalk in gastrointestinal inflammation and carcinogenesis
2017 Standout
The PPARα Activator Fenofibrate Slows Down the Progression of the Left Ventricular Dysfunction in Porcine Tachycardia-Induced Cardiomyopathy
2007
Gut Microbiota Regulates Bile Acid Metabolism by Reducing the Levels of Tauro-beta-muricholic Acid, a Naturally Occurring FXR Antagonist
2013 Standout
A Systematic Comparison of the Properties of Clinically Used Angiotensin II Type 1 Receptor Antagonists
2013
High-Density Lipoprotein (HDL) Transport in the Metabolic Syndrome: Application of a New Model for HDL Particle Kinetics
2006
Metabolic Syndrome: Treatment of Hypertensive Patients
2007
Troglitazone stimulates β-arrestin-dependent cardiomyocyte contractility via the angiotensin II type 1A receptor
2010
Calcineurin Inhibitor Nephrotoxicity
2009 Standout
Differential Activation of Nuclear Receptors by Perfluorinated Fatty Acid Analogs and Natural Fatty Acids: A Comparison of Human, Mouse, and Rat Peroxisome Proliferator-Activated Receptor-α, -β, and -γ, Liver X Receptor-β, and Retinoid X Receptor-α
2006
Perfluoroalkyl Acids: A Review of Monitoring and Toxicological Findings
2007 Standout
Major Mango Polyphenols and Their Potential Significance to Human Health
2008 Standout
Renin-Angiotensin-Aldosterone System and Progression of Renal Disease
2006
Natural product agonists of peroxisome proliferator-activated receptor gamma (PPARγ): a review
2014 Standout
Bayesian Test for Colocalisation between Pairs of Genetic Association Studies Using Summary Statistics
2014 Standout
Cholesteryl ester transfer protein: at the heart of the action of lipid-modulating therapy with statins, fibrates, niacin, and cholesteryl ester transfer protein inhibitors
2009
Lipid‐sensing nuclear receptors in the pathophysiology and treatment of the metabolic syndrome
2011
Peroxisome proliferator-activated receptor-alpha (PPARα): At the crossroads of obesity, diabetes and cardiovascular disease
2009
Human nutrition, the gut microbiome and the immune system
2011 StandoutNature
Beyond intestinal soap—bile acids in metabolic control
2014
Gut microbiome and health: mechanistic insights
2022 Standout
Therapeutic potential of β-arrestin- and G protein-biased agonists
2010 StandoutNobel
A Human Monoclonal Antibody Targeting Scavenger Receptor Class B Type I Precludes Hepatitis C Virus Infection and Viral Spread In Vitro and In Vivo
2011 StandoutNobel
Functional interactions between the gut microbiota and host metabolism
2012 StandoutNature
FXR Acetylation Is Normally Dynamically Regulated by p300 and SIRT1 but Constitutively Elevated in Metabolic Disease States
2009
Emerging concepts in the science of vaccine adjuvants
2021
CD8+ effector T cells contribute to macrophage recruitment and adipose tissue inflammation in obesity
2009 Standout
Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial
2014 Standout
PPARγ signaling and metabolism: the good, the bad and the future
2013 Standout
PPARα and PPARγ dual agonists for the treatment of type 2 diabetes and the metabolic syndrome
2006
Angiotensin inhibition enhances drug delivery and potentiates chemotherapy by decompressing tumour blood vessels
2013 StandoutNobel
Hypolipidemic therapy for the metabolic syndrome
2006
Proteasomal degradation of retinoid X receptor α reprograms transcriptional activity of PPARγ in obese mice and humans
2010
Intestinal Crosstalk between Bile Acids and Microbiota and Its Impact on Host Metabolism
2016 Standout
Discovery and development of selective PPARγ modulators as safe and effective antidiabetic agents
2010
Bile acids as regulatory molecules
2009
Progress and challenges in translating the biology of atherosclerosis
2011 StandoutNature
Energy Metabolism in the Liver
2014 Standout
High-Density Lipoprotein Subfractions - What the Clinicians Need to Know
2013 Standout
Biosynthesis and biotechnological production of ginsenosides
2015 Standout
Dyslipidaemia of Obesity, Metabolic Syndrome and Type 2 Diabetes Mellitus: the Case for Residual Risk Reduction After Statin Treatment
2011
Peroxisome Proliferator–Activated Receptors as Transcriptional Nodal Points and Therapeutic Targets
2007
Analysis of the Structural Diversity, Substitution Patterns, and Frequency of Nitrogen Heterocycles among U.S. FDA Approved Pharmaceuticals
2014 Standout
Myocardial Fatty Acid Metabolism in Health and Disease
2010 Standout
T-lymphocyte Infiltration in Visceral Adipose Tissue
2008
Bile acids in glucose metabolism in health and disease
2018
Pathophysiology of Type 2 Diabetes Mellitus
2020 Standout
The Metabolic Syndrome
2008 Standout
Amorfrutins are potent antidiabetic dietary natural products
2012
Effects of the Mango Components Mangiferin and Quercetin and the Putative Mangiferin Metabolite Norathyriol on the Transactivation of Peroxisome Proliferator-Activated Receptor Isoforms
2008
Macrophages, Inflammation, and Insulin Resistance
2010 Standout
Chemically Modified Bacterial Sacculi as a Vaccine Microparticle Scaffold
2022 StandoutNobel
Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults--The Evidence Report. National Institutes of Health.
1998 Standout
Farnesoid X Receptor Inhibits the Transcriptional Activity of Carbohydrate Response Element Binding Protein in Human Hepatocytes
2013
Works of Romain Gineste being referenced
Activation of the endoplasmic reticulum stress sensor IRE1α by the vaccine adjuvant AS03 contributes to its immunostimulatory properties
2018
Lysosome-Dependent Activation of Human Dendritic Cells by the Vaccine Adjuvant QS-21
2017
Regulation of Human ApoA-I by Gemfibrozil and Fenofibrate Through Selective Peroxisome Proliferator-Activated Receptor α Modulation
2004
Phosphorylation of Farnesoid X Receptor by Protein Kinase C Promotes Its Transcriptional Activity
2008
Molecular Characterization of New Selective Peroxisome Proliferator–Activated Receptor γ Modulators With Angiotensin Receptor Blocking Activity
2005